Yahoo Web Search

Search results

  1. Mar 25, 2024 · Non-Proprietary Name. The non-proprietary name of a drug is the name accepted by a competent scientific body or authority, such as the USAN or BAN. The non-proprietary names of newer drugs are kept uniform by an agreement to use the Recommended International Nonproprietary Name (rINN) in all member countries of the World Health Organization (WHO).

  2. Apr 13, 2021 · The World Health Organization assigns international nonproprietary names (INN), also known as common names, to compounds upon request from drug developers. Structures of INNs are publicly available and represent a source, albeit underused, to understand trends in drug research and development.

    • Marta Serafini, Sarah Cargnin, Alberto Massarotti, Gian Cesare Tron, Tracey Pirali, Armando A Genazz...
    • 2021
  3. Drug nomenclature is the systematic naming of drugs, especially pharmaceutical drugs. In the majority of circumstances, drugs have 3 types of names: chemical names, the most important of which is the IUPAC name; generic or nonproprietary names, the most important of which are international nonproprietary names (INNs); and trade names, which are ...

  4. Feb 21, 2023 · Every biologic and biosimilar has a non-proprietary (“generic”) and proprietary (“brand”) name. Similar to other medications, non-proprietary names also incorporate common stems. For example, biologics like trastuzumab and rituximab share the -mab stem. This stem means these medications are both monoclonal antibodies.

  5. Oct 11, 2023 · Drugs are also known by generic, non- proprietary or official names. This is the name given to a drug after it might have been found to be of therapeutic use. It is the name with which the drug is described in official books of reference like pharmacopoeias.

  6. Jun 6, 2020 · Drugs often have several names. A marketed drug may have up to four different types of names: a chemical name, a company name, a generic name, and a brand name. • Chemical name: When a drug is first discovered, it is given a chemical name. This describes the atomic or molecular structure of the drug. The chemical name is thus usually too complex and cumbersome for general use and is almost ...

  7. People also ask

  8. Jan 18, 2017 · 1 The Guidance defines “related biological product” as “a biological product submitted in a Biologics License Application (BLA) under section 351(a) of the Public Health Service Act (i.e., a stand-alone BLA) for which there is a previously licensed biological product submitted in a different section 351(a) BLA that contains a drug ...